Walpar Nutritions Limited is an India-based company, which is engaged in manufacturing and trading of pharmaceutical, nutraceutical, herbal and ayurvedic commodities. It also manufactures various private label/third party brands for different companies across the country and overseas, as well as for their own brand sales. It is a manufacturer of various types of nutraceutical formulation, pharmaceutical ingredients, and pharmaceutical formulations. It specializes in contract manufacturing, raw materials trading, and direct selling. Its portfolio consists of tablets, capsules, powder/sachets, and oral liquids. Its products include Pcos Care Forte, Procive-F, Procive-M, Proplus, BIOMID, FERROF, FTM-plus, FTW-plus, G-Flora INOSIA-F, Joint-CR, NI-1000, Ortin-5, Ova-Wom, PCOS-CARE, Refitil-F, Refitil-M, Seagut, Spinac, TRIVITA, flaxseed- Oil, Ironica-CR, Magorich, PDF, PIYO, and Ashyuka Plus. Its subsidiaries include Walpar Wellness Private Limited and Walpar Nutri Science Private Limited.As of 30 May 2026, WALPAR NUTRITIONS LIMITED share price is ₹32.95. The stock opened at ₹36.35, compared to its previous close of ₹34.65. During today's trading session, WALPAR NUTRITIONS LIMITED share price moved in the range of ₹32.95 to ₹36.35, with an average price of ₹34.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹32.95 and a high of ₹36.35. On the performance front, WALPAR NUTRITIONS LIMITED share price has declined by 20.12% over the last six months and is down 28.37% on a year-on-year basis.
The market capitalization of WALPAR NUTRITIONS LIMITED is ₹40 Crs, with a P/E ratio of 18.3 and a dividend yield of 0.00%.